We are live on ! Find out more
LBPH

Longboard Pharmaceuticals, Inc. Common Stock
LBPH

Delisted

LBPH was delisted on the 29th of November, 2024.

Back to rankings

22 hedge funds and large institutions have $143M invested in Longboard Pharmaceuticals, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 22 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
22
Holders Change
+22
Holders Change %
–
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
+$38.5M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$37.6M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$32.6M
4
FCM
Farallon Capital Management
California
+$13.2M
5
Citigroup
Citigroup
New York
+$6.63M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CAM
1
Cormorant Asset Management
Massachusetts
$37.2M +$38.5M +2,356,000 New
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$36.2M +$37.6M +2,302,749 New
Fidelity Investments
3
Fidelity Investments
Massachusetts
$32.5M +$32.6M +1,993,136 New
FCM
4
Farallon Capital Management
California
$13.3M +$13.2M +810,500 New
Citigroup
5
Citigroup
New York
$6.62M +$6.63M +405,645 New
O
6
OrbiMed
New York
$4.91M +$4.9M +300,000 New
Millennium Management
7
Millennium Management
New York
$3.11M +$3.11M +190,349 New
Citadel Advisors
8
Citadel Advisors
Florida
$2.96M +$2.97M +181,473 New
Alyeska Investment Group
9
Alyeska Investment Group
Illinois
$2.05M +$2.04M +125,000 New
Vanguard Group
10
Vanguard Group
Pennsylvania
$900K +$899K +55,000 New
IHAM
11
Integral Health Asset Management
New York
$491K +$490K +30,000 New
Goldman Sachs
12
Goldman Sachs
New York
$410K +$409K +25,000 New
DKCM
13
Davidson Kempner Capital Management
New York
$405K +$409K +25,000 New
LCM
14
Laurion Capital Management
New York
$398K +$399K +24,400 New
TD Asset Management
15
TD Asset Management
Ontario, Canada
$277K +$278K +16,993 New
ECM
16
Endurant Capital Management
California
$267K +$267K +16,327 New
ECM
17
ExodusPoint Capital Management
New York
$246K +$245K +15,011 New
Wellington Management Group
18
Wellington Management Group
Massachusetts
$185K +$185K +11,333 New
Jane Street
19
Jane Street
New York
$174K +$173K +10,606 New
MS
20
Maven Securities
Jersey
$128K +$128K +7,813 New
UBS Group
21
UBS Group
Switzerland
$10K +$9.74K +596 New
Bank of America
22
Bank of America
North Carolina
$7K +$6.61K +404 New

LBPH Hedge Fund Activity: Q1 2021 in Review

22 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Longboard Pharmaceuticals, Inc. Common Stock (LBPH) for Q1 2021, worth a combined $143M.

Buyers outnumbered sellers: 22 funds opened new LBPH positions and 0 closed out — a net gain of 22 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $38.5M.

  • 22 institutional investors held Longboard Pharmaceuticals, Inc. Common Stock (LBPH) as of Q1 2021, up from 0 in Q4 2020.
  • Funds reported $143M of Longboard Pharmaceuticals, Inc. Common Stock stock for Q1 2021.
  • 22 funds opened new Longboard Pharmaceuticals, Inc. Common Stock positions in Q1 2021 and 0 closed out, a net change of +22 holders.
  • The largest Longboard Pharmaceuticals, Inc. Common Stock buyer in Q1 2021 was Cormorant Asset Management, an estimated $38.5M added.

Based on aggregated 13F filings for Q1 2021.